| 4/19/10 09:01 | 4/16/10 | MYRX | Myriad Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hobden Adrian N | UT | DO | P,CEO | M.d | 39 | 1.38 | 1 | 28 | 21 | 163 | D |  |  | -20 | 2 | 8 | 9 | 13 | 1 | -1 | -1 | -21 | -27 | -25 | -17 | 
| 3/19/10 16:20 | 3/18/10 | MYRX | Myriad Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hobden Adrian N | UT | DO | P,CEO | P | 88 | 4.41 | 1 | 20 | 17 | 135 | D |  |  | -30 | -19 | -2 | -10 | -9 | -5 | 5 | 3 | 13 | -8 | -12 | -16 | 
| 3/4/10 16:07 | 3/2/10 | MYRX | Myriad Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hobden Adrian N | UT | DO | P,CEO | M.d | 5 | 1.23 | 1 | 4 | 4 | 115 | D |  |  | 7 | -4 | -1 | 14 | 0 | 0 | -2 | 1 | -4 | -15 | -22 | -19 | 
| 6/8/09 17:30 | 6/8/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 400 | 10.76 | 33 | 37 | 19 | 234 | D | 96 | 54 | 24 | -5 | -3 | 13 | 10 | -2 | 3 | 5 | -24 | -6 | -25 | -44 | 
| 5/29/09 15:58 | 5/27/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 96 | 2.39 | 33 | 40 | 26 | 196 | D | 81 | 46 | 15 | -14 | -23 | 9 | 8 | 8 | 3 | 5 | 3 | -3 | -26 | -42 | 
| 5/29/09 15:58 | 5/27/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -1,361 | 34.01 | 33 | -40 | -17 | 196 | D | 81 | 46 | 15 | -14 | -23 | 9 | 8 | 8 | 3 | 5 | 3 | -3 | -26 | -42 | 
| 5/11/09 16:07 | 5/8/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 100 | 5.64 | 33 | 18 | 10 | 196 | D | 61 | 49 | -14 | -27 | -31 | -29 | -22 | -9 | 1 | 1 | 15 | -11 | -18 | -41 | 
| 2/5/09 16:26 | 2/5/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 115 | 4.78 | 33 | 24 | 37 | 89 |  |  |  |  |  |  |  |  |  | 1 | 3 | -7 | -23 | -31 | -39 | 
| 2/5/09 16:26 | 2/5/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -2,006 | 83.60 | 33 | -24 | -21 | 89 |  |  |  |  |  |  |  |  |  | 1 | 3 | -7 | -23 | -31 | -39 | 
| 12/11/08 17:41 | 12/11/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 96 | 4.78 | 33 | 20 | 29 | 89 | D | 91 | 24 | 33 | -9 | 5 | -3 | 6 | -4 | 2 | 8 | 12 | 36 | 25 | -11 | 
| 12/11/08 17:41 | 12/11/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -1,212 | 60.60 | 33 | -20 | -18 | 89 | D | 91 | 24 | 33 | -9 | 5 | -3 | 6 | -4 | 2 | 8 | 12 | 36 | 25 | -11 | 
| 9/30/08 18:09 | 9/29/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 108 | 5.13 | 33 | 21 | 31 | 89 | D | 169 | 24 | 57 | 42 | -1 | 2 | 3 | -2 | 1 | -8 | -13 | 0 | 40 | -7 | 
| 9/25/08 18:38 | 9/23/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 51 | 5.13 | 33 | 10 | 17 | 68 | D | 180 | 32 | 61 | 38 | -2 | 2 | 2 | 1 | 0 | -4 | -13 | -4 | 34 | -13 | 
| 9/25/08 18:38 | 9/25/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -1,028 | 68.54 | 33 | -15 | -18 | 68 | D | 180 | 32 | 61 | 38 | -2 | 2 | 2 | 1 | 0 | -4 | -13 | -4 | 34 | -13 | 
| 9/23/08 17:49 | 9/19/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 5 | 5.13 | 33 | 1 | 1 | 73 | D | 156 | 36 | 63 | 32 | -8 | -8 | -5 | -1 | 5 | 3 | -1 | 4 | 29 | 1 | 
| 9/23/08 17:49 | 9/19/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -65 | 66.00 | 33 | -1 | -1 | 73 | D | 156 | 36 | 63 | 32 | -8 | -8 | -5 | -1 | 5 | 3 | -1 | 4 | 29 | 1 | 
| 9/19/08 16:47 | 9/17/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.dm | 54 | 5.13 | 33 | 11 | 17 | 73 | D | 157 | 34 | 72 | 25 | -3 | -7 | -1 | -2 | -3 | 5 | -12 | 0 | 21 | 1 | 
| 9/19/08 16:47 | 9/17/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -33 | 66.49 | 33 | -1 | -1 | 73 | D | 157 | 34 | 72 | 25 | -3 | -7 | -1 | -2 | -3 | 5 | -12 | 0 | 21 | 1 | 
| 8/27/08 17:11 | 8/25/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 141 | 5.13 | 33 | 27 | 77 | 63 | D | 162 | 53 | 72 | 35 | 10 | -1 | -1 | 2 | 1 | -1 | 2 | -9 | 22 | 2 | 
| 8/27/08 17:11 | 8/25/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -1,786 | 65.03 | 33 | -27 | -30 | 63 | D | 162 | 53 | 72 | 35 | 10 | -1 | -1 | 2 | 1 | -1 | 2 | -9 | 22 | 2 | 
| 3/12/08 14:04 | 3/10/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 51 | 5.13 | 33 | 10 | 19 | 63 | D | 36 | 5 | -22 | -30 | -18 | -6 | -5 | -2 | 0 | 1 | 18 | 30 | 79 | 122 | 
| 12/4/07 17:24 | 11/30/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 26 | 5.13 | 33 | 5 | 11 | 52 | D | 150 | 58 | 30 | 8 | -7 | -1 | 4 | -2 | 2 | 4 | -5 | -22 | 1 | 23 | 
| 9/27/07 16:15 | 9/25/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 103 | 5.13 | 33 | 20 | 73 | 47 | D | 157 | 115 | 50 | 37 | 26 | 13 | 11 | 10 | 0 | 6 | -1 | -7 | -23 | 32 | 
| 9/27/07 16:15 | 9/25/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -1,000 | 50.00 | 33 | -20 | -30 | 47 | D | 157 | 115 | 50 | 37 | 26 | 13 | 11 | 10 | 0 | 6 | -1 | -7 | -23 | 32 | 
| 5/23/07 17:23 | 5/23/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 51 | 5.13 | 33 | 10 | 27 | 47 | D | 125 | 60 | 32 | 15 | 11 | 2 | 5 | 5 | -3 | -2 | -8 | 6 | 13 | 16 | 
| 5/23/07 17:23 | 5/23/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -400 | 40.00 | 33 | -10 | -18 | 47 | D | 125 | 60 | 32 | 15 | 11 | 2 | 5 | 5 | -3 | -2 | -8 | 6 | 13 | 16 | 
| 1/3/07 15:45 | 1/3/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 26 | 5.13 | 24 | 5 | 12 | 47 | D | 38 | 49 | 24 | 27 | 4 | 0 | 1 | 0 | 0 | 4 | 14 | 13 | 22 | 47 | 
| 1/3/07 15:45 | 1/3/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -160 | 32.00 | 24 | -5 | -10 | 47 | D | 38 | 49 | 24 | 27 | 4 | 0 | 1 | 0 | 0 | 4 | 14 | 13 | 22 | 47 | 
| 4/27/06 13:56 | 4/27/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 26 | 5.13 | 16 | 5 | 12 | 46 |  |  |  |  |  |  |  |  |  | 0 | 6 | -3 | -5 | 5 | 41 | 
| 4/27/06 13:56 | 4/27/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -130 | 26.01 | 16 | -5 | -10 | 46 |  |  |  |  |  |  |  |  |  | 0 | 6 | -3 | -5 | 5 | 41 | 
| 1/14/05 11:13 | 1/13/05 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 10 | 5.13 | 31 | 2 | 5 | 44 | D | 55 | 57 | 79 | 44 | 18 | 6 | 11 | 4 | 3 | 6 | -8 | -28 | -27 | -5 | 
| 1/14/05 11:13 | 1/13/05 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | S.d | -51 | 25.00 | 31 | -2 | -4 | 44 | D | 55 | 57 | 79 | 44 | 18 | 6 | 11 | 4 | 3 | 6 | -8 | -28 | -27 | -5 | 
| 8/6/04 16:16 | 8/5/04 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hobden Adrian N | UT | O | P Myriad | M.d | 15 | 5.13 | 7 | 3 | 7 | 43 | D | -33 | -5 | -20 | -29 | -9 | -3 | -5 | -3 | -4 | 3 | 28 | 41 | 94 | 38 |